Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Atossa Therapeutics, Inc.

NASDAQ: ATOS · Life Sciences · 5 alerts · CIK 1488039

Share price
$1.93Close, Nov 16
Market cap
$19.3M
Shares outstanding
9.98MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Atossa Therapeutics, Inc. filings on SEC EDGAR ↗

8:00 AM ET 8-K
Other 8-K Filing

Atossa Therapeutics Other 8-K Filing

Atossa Therapeutics announced a plan to issue one contingent value right (CVR) for each share of common stock, allowing shareholders to receive 25% of net proceeds from the potential monetization of its first qualifying FDA rare pediatric disease priority review voucher. The CVR payments are subject to an aggregate cap of $50 million and are tied to the company's (Z)-endoxifen development programs. The CVRs will be 'stapled' to the common stock and will not trade separately.

Term
through Dec 31, 2036

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.